Vitamin D supplementation during the first year of life and risk of schizophrenia: A Finnish birth cohort study

Schizophrenia Research

Volumn 67, Issue 2-3, 2004, Pages 237-245

  McGrath, John ^a,b   Saari, Kaisa ^c,d   Hakko, Helinä ^c,d   Jokelainen, Jari ^c,d   Jones, Peter ^e   Järvelin, Marjo Riitta ^c,f   Chant, David ^a   Isohanni, Matti ^c  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

1,25 Dihydroxyvitamin D3; Brain growth and development; Schizophrenia

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RISK ASSESSMENT; RISK REDUCTION; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 1342300633     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2003.08.005     Document Type: Article

References (39)

1. Abrams S.A. Nutritional rickets: an old disease returns. Nutr. Rev. 60(4):2002;111-115.
2. Ala-Houhala M. 25-Hydroxyvitamin D levels during breast-feeding with or without maternal or infantile supplementation of vitamin D. J. Pediatr. Gastroenterol. Nutr. 4(2):1985;220-226.
3. Barker D.J. Mothers, Babies and Health in Later Life. 1998;Churchill Livingstone, Edinburgh.
4. Brown A.S., Susser E.S., Butler P.D., Richardson A.R., Kaufmann C.A., Gorman J.M. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J. Nerv. Ment. Dis. 184(2):1996;71-85.
5. Davies, G., Welham, J., Chant, D.C., Torrey, E.F., McGrath, J., in press. Season of birth effect and latitude: a systematic review and meta-analysis of Northern Hemisphere studies. Schizophr. Bull.
6. DeLuca H.F., Zierold C. Mechanisms and functions of vitamin D. Nutr. Rev. 56(2 Pt 2):1998;S4-S10. (discussion S54-75).
7. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience. 118(3):2003;641-653.
8. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13(3):2002;100-105.
9. Hallman N., Hultin H., Visakorpi J.K. Riisitaudin ennakkotorjunnasta. Duodecim. 80:1964;185-189.
10. Hewison M. Vitamin D and the immune system. J. Endocrinol. 132(2):1992;173-175.
11. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 61(3 Suppl.):1995;638S-645S.
12. Hyppönen, E., 2001. Growth and nutrition in the etiology of Type I diabetes. Faculty of Medicine, University of Tampere, Tampere, p. 63.
13. Hyppönen E., Läärä E., Reunanen A., Järvelin M.R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 358(9292):2001;1500-1503.
14. Isohanni M., Makikyro T., Moring J., Rasanen P., Hakko H., Partanen U., Koiranen M., Jones P. A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia. Soc. Psychiatry Psychiatr. Epidemiol. 32(5):1997;303-308.
15. Isohanni M., Jones P., Kemppainen L., Croudace T., Isohanni I., Veijola J., Rasanen S., Wahlberg K.E., Tienari P., Rantakallio P. Childhood and adolescent predictors of schizophrenia in the Northern Finland 1966 birth cohort - a descriptive life-span model. Eur. Arch. Psychiatry Clin. Neurosci. 250(6):2000;311-319.
16. Isohanni M., Jones P.B., Moilanen K., Rantakallio P., Veijola J., Oja H., Koiranen M., Jokelainen J., Croudace T., Jarvelin M. Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Schizophr. Res. 52(1-2):2001;1-19.
17. Jones P.B., Rantakallio P., Hartikainen A.L., Isohanni M., Sipila P. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort. Am. J. Psychiatry. 155(3):1998;355-364.
18. Kokkonen J., Koivisto M., Kirkinen P. Seasonal variation in serum-25-OH-D3 in mothers and newborn infants in northern finland. Acta Paediatr. Scand. 72(1):1983;93-96.
19. Lucas A., Morley R., Cole T.J. Randomised trail of early diet in preterm babies and later intelligence quotient. Br. Med. J. 317:1998;1481-1487.
20. Makikyro T., Isohanni M., Moring J., Oja H., Hakko H., Jones P., Rantakallio P. Is a child's risk of early onset schizophrenia increased in the highest social class? Schizophr. Res. 23(3):1997;245-252.
21. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr. Res. 40(3):1999;173-177.
22. McGrath J., Eyles D., Mowry B., Yolken R., Buka S. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr. Res. 63(1-2):2003;73-78.
23. McGrath J., Feron F., Eyles D. Vitamin D: the neglected neurosteroid? Trends Neurosci. 24(10):2001;570-572.
24. Moilanen K., Veijola J., Laksy K., Makikyro T., Miettunen J., Kantojarvi L., Kokkonen P., Karvonen J.T., Herva A., Joukamaa M., Jarvelin M.R., Moring J., Jones P.B., Isohanni M. Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort. Soc. Psychiatry Psychiatr. Epidemiol. 38(6):2003;305-310.
25. Moskovitz R.A. Seasonality in schizophrenia [letter]. Lancet. 1(8065):1978;664.
26. Myhrman A., Rantakallio P., Isohanni M., Jones P., Partanen U. Unwantedness of a pregnancy and schizophrenia in the child. Br. J. Psychiatry. 169(5):1996;637-640.
27. Pile W.J. A study of the correlation between dementia praecox and the month of birth. Va. Med. Mon. 78:1951;438-440.
28. Prüfer K., Veenstra T.D., Jirikowski G.F., Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 16(2):1999;135-145.
29. Rose G. The Strategy of Preventive Medicine. 1992;Oxford Univ. Press, Oxford.
30. Rothman K.J. Modern Epidemiology. 1986;Little Brown and Co. Boston.
31. Schaefer C.A., Brown A.S., Wyatt R.J., Kline J., Begg M.D., Bresnahan M.A., Susser E.S. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr. Bull. 26(2):2000;275-286.
32. Susser E., Hoek H.W., Brown A. Neurodevelopmental disorders after prenatal famine: the story of the Dutch Famine Study. Am. J. Epidemiol. 147(3):1998;213-216.
33. Susser E., Neugebauer R., Hoek H., Brown A.S., Lin S., Labovitz D., Gorman J.M. Schizophrenia after prenatal famine: further evidence. Arch. Gen. Psychiatry. 53:1996;25-31.
34. Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R., McLachlan D.R. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28 k mRNA levels. Brain Res. Mol. Brain Res. 13(3):1992;239-250.
35. Suvisaari J.M., Haukka J.K., Tanskanen A.J., Lonnqvist J.K. Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch. Gen. Psychiatry. 56(8):1999;733-740.
36. Suvisaari J.M., Haukka J.K., Tanskanen A.J., Lonnqvist J.K. Decreasing seasonal variation of births in schizophrenia. Psychol. Med. 30(2):2000;315-324.
37. 3 receptors in the central nervous system of the rat embryo. Brain Res. 804:1998;193-205.
38. Wahlbeck K., Forsen T., Osmond C., Barker D.J., Eriksson J.G. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood. Arch. Gen. Psychiatry. 58(1):2001;48-52.
39. Webb A.R., Kline L., Holick M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab. 67(2):1988;373-378.